Needle-free COVID-19 intranasal vaccine provides broad immunity

COVID-19 intranasal vaccine. Credit: Griffith University A next-generation COVID-19 mucosal vaccine is set to be a gamechanger not only when delivering the vaccine itself, but also for people who are needle-phobic. New Griffith University research, “A single-dose intranasal live-attenuated codon deoptimized vaccine provides broad protection against SARS-CoV-2 and its variants” published in Nature Communications, has been testing the efficacy of delivering a COVID-19 vaccine via the nasal passages. Professor Suresh Mahalingam from Griffith’s Institute for Biomedicine and Glycomics has been working on this research for the past four years. “This is a live attenuated intranasal vaccine, called CDO-7N-1, designed to Read More